CD8A and neoplasm: On the other hand, PDP binds to PD-L1 molecules on the surface of tumor cells, blocks the interaction of PD-1/PD-L1, sensitizes drug-resistant CD8+ T cells, and enhances the effect of killing tumor cells (Figure 1).